Boiron SA (id:10729 BOI)
26.95 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 11/27/2024 5:38:30 PM)
Exchange closed, opens in 15 hours 21 minutes
About Boiron SA
Market Capitalization 543.44M
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
| Headquarters (address) |
2, avenue de l’Ouest Lyonnais Messimy 69510 France |
| Phone | 33 4 78 45 61 00 |
| Website | https://www.boiron.fr |
| Employees | 2,788 |
| Sector | Healthcare |
| Industry | Drug Manufacturers Specialty & Generic |
| Ticker | BOI |
| Exchange | European Stock Exchange |
| Currency | EUR |
| 52 week range | 27.50 - 42.80 |
| Market Capitalization | 543.44M |
| Dividend yield forward | 19.42 % |
| Dividend yield forward France (ID:70, base:257) | 16.26 % |
| P/E trailing | 23.01 |
| P/E forward | 14.42 |
| Price/Sale | 1.13 |
| Price/Book | 1.46 |
| Beta | 0.453 |
| EPS | 1.36 |
| EPS France (ID:70, base:331) | -1.54 |
Dividend growth streak
Boiron SA has raised their dividend 1.00 years in a row. This is below the 4.478450 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Boiron SA has raised their dividend 19.42 years in a row. This is below the 41466.238800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Boiron SA has raised their dividend 128.70 years in a row. This is above the 24.033000 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Boiron SA has raised their dividend 51.00 years in a row. This is above the 12.576000 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Boiron SA has raised their dividend 30.16 years in a row. This is above the 10.158800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Boiron SA has raised their dividend 99.26 years in a row. This is below the 147.817700 year average in the 'Drug Manufacturers Specialty & Generic' industry
Dividend growth streak
Boiron SA has raised their dividend 1.00 years in a row. This is below the 4.478450 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Boiron SA has raised their dividend 19.42 years in a row. This is below the 41466.238800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Boiron SA has raised their dividend 128.70 years in a row. This is above the 24.033000 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Boiron SA has raised their dividend 51.00 years in a row. This is above the 12.576000 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Boiron SA has raised their dividend 30.16 years in a row. This is above the 10.158800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Boiron SA has raised their dividend 99.26 years in a row. This is below the 147.817700 year average in the 'Drug Manufacturers Specialty & Generic' industry